Encephalopathy and Memory loss
Summary:
Memory loss is found among people with Encephalopathy, especially for people who are female, 60+ old.
The study analyzes which people have Memory loss with Encephalopathy. It is created by eHealthMe based on reports of 13 people who have Encephalopathy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Encephalopathy?
Encephalopathy (functioning of the brain is affected by some agent or condition) is found to be associated with 1,467 drugs and 1,602 conditions by eHealthMe. Check the latest studies of Encephalopathy.
What is Memory loss?
Memory loss is found to be associated with 2,728 drugs and 4,375 conditions by eHealthMe. Check the latest studies of Memory loss.
13 people who have Encephalopathy and Memory Loss are studied.

Gender of people who have Encephalopathy and experienced Memory Loss *:
- female: 61.54 %
- male: 38.46 %
Age of people who have Encephalopathy and experienced Memory Loss *:
- 0-1: 0.0 %
- 2-9: 11.11 %
- 10-19: 22.22 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 11.11 %
- 50-59: 11.11 %
- 60+: 44.44 %
Common co-existing conditions for these people *:
- Liver Disorder (liver diseases): 2 people, 15.38%
- Thyroid Diseases: 1 person, 7.69%
- Gastrointestinal Infection (infection of stomach and intestine): 1 person, 7.69%
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 7.69%
- Arthropathy: 1 person, 7.69%
- Blood Disorder: 1 person, 7.69%
- Cerebrosclerosis (hardening of the substance of the cerebrum): 1 person, 7.69%
- Cirrhosis Alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism): 1 person, 7.69%
- Complex Partial Seizures (epileptic seizure): 1 person, 7.69%
- Depression: 1 person, 7.69%
Common drugs taken by these people *:
- Xifaxan: 4 people, 30.77%
- Keppra: 2 people, 15.38%
- Tegretol: 2 people, 15.38%
- Lyrica: 2 people, 15.38%
- Zofran: 1 person, 7.69%
- Dexamethasone: 1 person, 7.69%
- Lactulose: 1 person, 7.69%
- Hydrocortisone: 1 person, 7.69%
- Humalog: 1 person, 7.69%
- Generlac: 1 person, 7.69%
Common symptoms for these people *:
- Drug Ineffective: 4 people, 30.77%
- Confusional State: 4 people, 30.77%
- Malaise (a feeling of general discomfort or uneasiness): 2 people, 15.38%
- Movement - Uncontrolled Or Slow: 2 people, 15.38%
- Headache (pain in head): 2 people, 15.38%
- Hearing Loss: 2 people, 15.38%
- Loss Of Consciousness: 2 people, 15.38%
- Fall: 2 people, 15.38%
- Ammonia Increased: 2 people, 15.38%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Memory loss?
- Check whether Memory loss is associated with a drug or a conditionRelated publications that referenced our studies
- Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .
- Kapoor A, Kumar V, Beniwal S, Dutta S, Goyal S, Kumar HS, "Posterior reversible encephalopathy syndrome in non-Hodgkin's lymphoma: Not necessarily reversible!", Clinical Cancer Investigation Journal, 2015 Mar .
Related studies:
Treatments, associated drugs and conditions:
- Encephalopathy (27,832 reports)
- Memory loss (244,444 reports)
All the drugs that are associated with Memory loss:
- Memory loss (2,728 drugs)
All the conditions that are associated with Memory loss:
- Memory loss (4,375 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Memory loss and Encephalopathy, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zofran and Ziac - 9 seconds ago
- How effective is Suboxone for Drug Dependence? - 13 seconds ago
- Drug interactions of Algin and Sucralfate - 22 seconds ago
- Could Fuzeon cause Hypokalemia? - 35 seconds ago
- Could Mektovi cause Swallowing Difficulty? - 35 seconds ago
- Low Density Lipoprotein Abnormal and Heart Palpitations - 48 seconds ago
- Could Novolog cause Gallbladder Operation? - 49 seconds ago
- Sepsis and Chills - a minute ago
- Could Hctz cause Skin Discoloration - Bluish? - a minute ago
- Could Lidocaine cause Bleeding Into The Skin? - a minute ago